![]()
|
|
||||||||
(Received for publication, April 1, 1996, and in revised form, June 17, 1996)
From the Department of Biochemistry and Molecular Biology, Indiana
University School of Medicine, Indianapolis, Indiana 46202
The self-glucosylating proteins, Glg1p and Glg2p,
are required for glycogen synthesis in Saccharomyces
cerevisiae (Cheng, C., Mu., J., Farkas, I., Huang, D., Goebl M. G., and Roach, P. J. (1995) Mol. Cell. Biol. 15, 6632-6640). Glg2p was shown to be associated with carbohydrate
in vivo and was released from the high molecular weight
glycogen fraction by treatment with
Volume 271, Number 43,
Issue of October 25, 1996
pp. 26554-26560
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
REQUIREMENT OF MULTIPLE TYROSINE RESIDUES FOR FUNCTION OF THE
SELF-GLUCOSYLATING Glg PROTEINS IN VIVO
-amylase. In addition, some
Glg2p exists as a protein of Mr ~43,000,
whose proportion is increased in cells lacking glycogen synthase.
Unlike the mammalian counterpart, glycogenin, the yeast Glg proteins
appear to require multiple Tyr residues for functionality. In Glg2p,
mutation of both Tyr230 and Tyr232 is necessary
to suppress self-glucosylation of purified protein in
vitro. The mutant protein is still capable of transferring
glucose to an exogeneous acceptor, n-dodecyl
-D-maltoside. A small COOH-terminal region, conserved
between Glg1p and Glg2p, is also important for function; mutation of
Tyr367 or truncation at residue 362 impairs the ability of
primed Glg2p to be elongated by glycogen synthase. Complete suppression
of glycogen accumulation in vivo requires mutation of all
three Tyr residues. In Glg1p, two Tyr residues are implicated,
Tyr232 and Tyr600, mutation of both being
required to eliminate glycogen accumulation in vivo.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Douillard-Guilloux, N. Raben, S. Takikita, L. Batista, C. Caillaud, and E. Richard Modulation of glycogen synthesis by RNA interference: towards a new therapeutic approach for glycogenosis type II Hum. Mol. Genet., December 15, 2008; 17(24): 3876 - 3886. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, W. A. Wilson, M. A. Fujino, and P. J. Roach Antagonistic Controls of Autophagy and Glycogen Accumulation by Snf1p, the Yeast Homolog of AMP-Activated Protein Kinase, and the Cyclin-Dependent Kinase Pho85p Mol. Cell. Biol., September 1, 2001; 21(17): 5742 - 5752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mu and P. J. Roach Characterization of Human Glycogenin-2, a Self-glucosylating Initiator of Liver Glycogen Metabolism J. Biol. Chem., December 25, 1998; 273(52): 34850 - 34856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mu, A. V. Skurat, and P. J. Roach Glycogenin-2, a Novel Self-glucosylating Protein Involved in Liver Glycogen Biosynthesis J. Biol. Chem., October 31, 1997; 272(44): 27589 - 27597. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |